Cite
HARVARD Citation
Pierot, L. et al. (2018). Feasibility, complications, morbidity, and mortality results at 6 months for aneurysm treatment with the Flow Re-Direction Endoluminal Device: report of SAFE study. Journal of neurointerventional surgery. pp. 765-770. [Online].